Hemab Therapeutics Holdings (COAG) PT Raised to $47 at Jefferies
Tweet
Share
E-mailGet Alerts COAG Hot Sheet
Price: $51.74 +3.75%
Rating Summary:
5 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 23 | New: 12
Rating Summary:
5 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 23 | New: 12
Join SI Premium – FREE
Jefferies analyst Maury Raycroft raised the price target on Hemab Therapeutics Holdings (NASDAQ: COAG) to $47.00 (from $39.00) while maintaining a Buy rating.
You May Also Be Interested In
- Hemab Therapeutics Holdings (COAG) PT Raised to $58 at Jefferies
- Freedom Broker Downgrades Critical Metals (CRML) to Hold
- Citi Upgrades Cosmax Inc (192820:KS) to Buy
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
